199 related articles for article (PubMed ID: 21147213)
1. Generation of human regulatory T cells de novo with suppressive function prevent xenogeneic graft versus host disease.
Qian X; Wang K; Wang X; Zheng SG; Lu L
Int Immunopharmacol; 2011 May; 11(5):630-7. PubMed ID: 21147213
[TBL] [Abstract][Full Text] [Related]
2. Generation of highly effective and stable murine alloreactive Treg cells by combined anti-CD4 mAb, TGF-β, and RA treatment.
Schliesser U; Chopra M; Beilhack A; Appelt C; Vogel S; Schumann J; Panov I; Vogt K; Schlickeiser S; Olek S; Wood K; Brandt C; Volk HD; Sawitzki B
Eur J Immunol; 2013 Dec; 43(12):3291-305. PubMed ID: 23946112
[TBL] [Abstract][Full Text] [Related]
3. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells.
Shan J; Feng L; Sun G; Chen P; Zhou Y; Xia M; Li H; Li Y
Immunobiology; 2015 Apr; 220(4):510-7. PubMed ID: 25468562
[TBL] [Abstract][Full Text] [Related]
4. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.
Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY
Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692
[TBL] [Abstract][Full Text] [Related]
5. Generation and large-scale expansion of human inducible regulatory T cells that suppress graft-versus-host disease.
Hippen KL; Merkel SC; Schirm DK; Nelson C; Tennis NC; Riley JL; June CH; Miller JS; Wagner JE; Blazar BR
Am J Transplant; 2011 Jun; 11(6):1148-57. PubMed ID: 21564534
[TBL] [Abstract][Full Text] [Related]
6. The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice.
Qu Y; Zhang B; Zhao L; Liu G; Ma H; Rao E; Zeng C; Zhao Y
Transpl Immunol; 2007 Apr; 17(3):153-61. PubMed ID: 17331841
[TBL] [Abstract][Full Text] [Related]
7. Human regulatory T cells control xenogeneic graft-versus-host disease induced by autologous T cells in RAG2-/-gammac-/- immunodeficient mice.
Mutis T; van Rijn RS; Simonetti ER; Aarts-Riemens T; Emmelot ME; van Bloois L; Martens A; Verdonck LF; Ebeling SB
Clin Cancer Res; 2006 Sep; 12(18):5520-5. PubMed ID: 17000688
[TBL] [Abstract][Full Text] [Related]
8. Rapamycin, unlike cyclosporine A, enhances suppressive functions of in vitro-induced CD4+CD25+ Tregs.
Bocian K; Borysowski J; Wierzbicki P; Wyzgal J; Klosowska D; Bialoszewska A; Paczek L; Górski A; Korczak-Kowalska G
Nephrol Dial Transplant; 2010 Mar; 25(3):710-7. PubMed ID: 19903662
[TBL] [Abstract][Full Text] [Related]
9. Ex-vivo expanded baboon CD4+ CD25 Hi Treg cells suppress baboon anti-pig T and B cell immune response.
Singh AK; Seavey CN; Horvath KA; Mohiuddin MM
Xenotransplantation; 2012; 19(2):102-11. PubMed ID: 22497512
[TBL] [Abstract][Full Text] [Related]
10. In vitro-expanded CD4(+)CD25(high)Foxp3(+) regulatory T cells controls corneal allograft rejection.
Guo X; Jie Y; Ren D; Zeng H; Zhang Y; He Y; Pan Z
Hum Immunol; 2012 Nov; 73(11):1061-7. PubMed ID: 22939904
[TBL] [Abstract][Full Text] [Related]
11. Rapamycin Combined with Immature Dendritic Cells Attenuates Obliterative Bronchiolitis in Trachea Allograft Rats by Regulating the Balance of Regulatory and Effector T Cells.
Dong M; Wang X; Liu J; Zhao YX; Chen XL; Li KQ; Li G
Int Arch Allergy Immunol; 2015; 167(3):177-85. PubMed ID: 26302996
[TBL] [Abstract][Full Text] [Related]
12. Differential responses of human regulatory T cells (Treg) and effector T cells to rapamycin.
Strauss L; Czystowska M; Szajnik M; Mandapathil M; Whiteside TL
PLoS One; 2009 Jun; 4(6):e5994. PubMed ID: 19543393
[TBL] [Abstract][Full Text] [Related]
13. Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells.
Shin HJ; Baker J; Leveson-Gower DB; Smith AT; Sega EI; Negrin RS
Blood; 2011 Aug; 118(8):2342-50. PubMed ID: 21734238
[TBL] [Abstract][Full Text] [Related]
14. Influence of sirolimus-induced TGF-β secretion on mouse Treg cell proliferation.
Li JN; Li JX; Huang HL; Zhu XL; Ding H; Huang CF; Lin J; Huang JG; Wu ZC; Ashraf M; Wang YG; Li XK; Zheng SY; Chen JM; Guo HM; Zhuang J; Zhu P
Genet Mol Res; 2015 Dec; 14(4):18569-79. PubMed ID: 26782505
[TBL] [Abstract][Full Text] [Related]
15. A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood.
Yamagiwa S; Gray JD; Hashimoto S; Horwitz DA
J Immunol; 2001 Jun; 166(12):7282-9. PubMed ID: 11390478
[TBL] [Abstract][Full Text] [Related]
16. Single and combined effect of retinoic acid and rapamycin modulate the generation, activity and homing potential of induced human regulatory T cells.
Candia E; Reyes P; Covian C; Rodriguez F; Wainstein N; Morales J; Mosso C; Rosemblatt M; Fierro JA
PLoS One; 2017; 12(7):e0182009. PubMed ID: 28746369
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid hormone differentially modulates the in vitro expansion and cytokine profile of thymic and splenic Treg cells.
Pap R; Ugor E; Litvai T; Prenek L; Najbauer J; Németh P; Berki T
Immunobiology; 2019 Mar; 224(2):285-295. PubMed ID: 30612787
[TBL] [Abstract][Full Text] [Related]
18. Rapamycin promotes the enrichment of CD4(+)CD25(hi)FoxP3(+) T regulatory cells from naïve CD4(+) T cells of baboon that suppress antiporcine xenogenic response in vitro.
Singh AK; Horvath KA; Mohiuddin MM
Transplant Proc; 2009; 41(1):418-21. PubMed ID: 19249569
[TBL] [Abstract][Full Text] [Related]
19. Soluble GARP has potent antiinflammatory and immunomodulatory impact on human CD4⁺ T cells.
Hahn SA; Stahl HF; Becker C; Correll A; Schneider FJ; Tuettenberg A; Jonuleit H
Blood; 2013 Aug; 122(7):1182-91. PubMed ID: 23818544
[TBL] [Abstract][Full Text] [Related]
20. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.
Chen W; Jin W; Hardegen N; Lei KJ; Li L; Marinos N; McGrady G; Wahl SM
J Exp Med; 2003 Dec; 198(12):1875-86. PubMed ID: 14676299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]